News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alcidion.
RELATED STOCKHEAD STORIES
News
Lunch Wrap: Domain soars 40pc on CoStar bid; GYG tumbles despite solid half
Health & Biotech
Health Check: CSL’s blood business saves the day amid declining flu jab rates
Health & Biotech
Digital prescription: ASX stocks transforming healthcare sector
Experts
Dr Boreham’s Crucible: Can this Aussie medtech rise as it lifts a cumbersome NHS into the digital age?
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
ASX Small Caps Lunch Wrap: We’re not living in a Materials world anymore. At least not today
Health & Biotech
ASX Health Stocks: Alcidion soars as it helps bring UK patient records into digital age
Health & Biotech
ASX Health Stocks: Immutep gets crucial therapy trial clearance; Alcidion wins $4m deal
News
Market Highlights: Records tumble, Powell to testify, and 5 ASX small caps to watch today
News
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
Health & Biotech
ASX Health Stocks: The secret is out – Chemist Warehouse plans ASX listing via Sigma healthcare merger
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
ASX Health Stocks: Neurotech gets approval to treat children patients until they are 20 years old
News
Market Highlights: NY and London closed; expert warns of downside correction in US stocks
Tech
The Nasdaq has just entered a new bull market – is the tide also turning for ASX Tech stocks?
Experts
CRITERION: In a wounded tech sector, these 10 stocks are tipped for a profitable year ahead
Health & Biotech
